Woodstock Corp trimmed its position in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 20.0% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 13,306 shares of the pharmacy operator’s stock after selling 3,330 shares during the period. Woodstock Corp’s holdings in Walgreens Boots Alliance were worth $478,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently modified their holdings of WBA. Balentine LLC bought a new stake in Walgreens Boots Alliance in the first quarter valued at $29,000. Northern Oak Wealth Management Inc. boosted its holdings in Walgreens Boots Alliance by 54.1% in the second quarter. Northern Oak Wealth Management Inc. now owns 715 shares of the pharmacy operator’s stock valued at $30,000 after acquiring an additional 251 shares in the last quarter. Campbell Wealth Management bought a new stake in Walgreens Boots Alliance in the second quarter valued at $35,000. Perennial Advisors LLC bought a new stake in Walgreens Boots Alliance in the first quarter valued at $36,000. Finally, Cornerstone Advisors Inc. boosted its holdings in Walgreens Boots Alliance by 47.5% in the second quarter. Cornerstone Advisors Inc. now owns 898 shares of the pharmacy operator’s stock valued at $38,000 after acquiring an additional 289 shares in the last quarter. 55.96% of the stock is currently owned by institutional investors.
Shares of Walgreens Boots Alliance stock opened at $35.77 on Friday. The stock has a market cap of $31.00 billion, a price-to-earnings ratio of 43.62, a PEG ratio of 1.35 and a beta of 0.43. The firm’s 50-day moving average is $37.62 and its 200 day moving average is $41.23. Walgreens Boots Alliance Inc has a 1 year low of $33.88 and a 1 year high of $64.50. The company has a debt-to-equity ratio of 0.57, a current ratio of 0.69 and a quick ratio of 0.33.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, July 9th. The pharmacy operator reported $0.83 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.10 by ($0.27). Walgreens Boots Alliance had a return on equity of 19.43% and a net margin of 0.55%. The firm had revenue of $34.63 billion during the quarter, compared to the consensus estimate of $34.32 billion. During the same quarter in the previous year, the firm earned $1.47 EPS. The business’s revenue for the quarter was up .1% on a year-over-year basis. On average, equities analysts expect that Walgreens Boots Alliance Inc will post 4.68 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which was paid on Friday, September 11th. Shareholders of record on Wednesday, August 19th were given a $0.4675 dividend. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.46. The ex-dividend date of this dividend was Tuesday, August 18th. This represents a $1.87 dividend on an annualized basis and a yield of 5.23%. Walgreens Boots Alliance’s payout ratio is 31.22%.
WBA has been the topic of several recent analyst reports. Citigroup cut their price target on shares of Walgreens Boots Alliance from $48.00 to $43.00 and set a “neutral” rating on the stock in a report on Friday, July 10th. Royal Bank of Canada dropped their target price on shares of Walgreens Boots Alliance from $45.00 to $38.00 and set a “sector perform” rating on the stock in a report on Wednesday, September 2nd. Mizuho dropped their target price on shares of Walgreens Boots Alliance from $43.00 to $37.00 and set a “neutral” rating on the stock in a report on Friday, September 11th. SunTrust Banks dropped their target price on shares of Walgreens Boots Alliance from $42.00 to $40.00 and set a “hold” rating on the stock in a report on Friday, July 10th. Finally, Bank of America dropped their target price on shares of Walgreens Boots Alliance from $43.00 to $40.00 and set an “underperform” rating on the stock in a report on Friday, July 10th. Four research analysts have rated the stock with a sell rating and fourteen have issued a hold rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $44.60.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Recommended Story: FinTech
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.